320 related articles for article (PubMed ID: 32141556)
1. LncRNA ASB16-AS1 promotes proliferation and inhibits apoptosis of non small cell lung cancer cells by activating the Wnt/β catenin signaling pathway.
Tan LJ; Liu JT; Yang M; Ju T; Zhang YS
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1870-1876. PubMed ID: 32141556
[TBL] [Abstract][Full Text] [Related]
2. LncRNA FBXL19-AS1 promotes proliferation and metastasis via regulating epithelial-mesenchymal transition in non-small cell lung cancer.
Yu DJ; Li YH; Zhong M
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4800-4806. PubMed ID: 31210311
[TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA ASB16-AS1 enhances cell proliferation, migration and invasion via functioning as a ceRNA through miR-1305/Wnt/β-catenin axis in cervical cancer.
Liu W; Zhuang R; Feng S; Bai X; Jia Z; Kapora E; Tan W
Biomed Pharmacother; 2020 May; 125():109965. PubMed ID: 32058219
[TBL] [Abstract][Full Text] [Related]
4. Low expression of LncRNA AFAP1-AS1 inhibits proliferation and promotes apoptosis of non-small cell lung cancer cells through inhibiting wnt signaling pathway.
Sun Y; Fan L; Li Y
Cell Mol Biol (Noisy-le-grand); 2023 Nov; 69(12):176-180. PubMed ID: 38063100
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of lncRNA NCK1-AS1 predicts poor prognosis and contributes to non-small cell lung cancer proliferation by regulating CDK1.
Zha LF; Zhang LD; Pan HM; Ma HD
Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1351-1357. PubMed ID: 33629305
[TBL] [Abstract][Full Text] [Related]
6. LncRNA FEZF1-AS1 enhances epithelial-mesenchymal transition (EMT) through suppressing E-cadherin and regulating WNT pathway in non-small cell lung cancer (NSCLC).
He R; Zhang FH; Shen N
Biomed Pharmacother; 2017 Nov; 95():331-338. PubMed ID: 28858731
[TBL] [Abstract][Full Text] [Related]
7. LncRNA NNT-AS1 is a major mediator of cisplatin chemoresistance in non-small cell lung cancer through MAPK/Slug pathway.
Cai Y; Dong ZY; Wang JY
Eur Rev Med Pharmacol Sci; 2018 Aug; 22(15):4879-4887. PubMed ID: 30070323
[TBL] [Abstract][Full Text] [Related]
8. Effects of lncRNA SNHG20 on proliferation and apoptosis of non-small cell lung cancer cells through Wnt/β-catenin signaling pathway.
Wang ZX; Zhao Y; Yu Y; Liu N; Zou QX; Liang FH; Cheng KP; Lin FW
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(1):230-237. PubMed ID: 31957836
[TBL] [Abstract][Full Text] [Related]
9. LncDBH-AS1 knockdown enhances proliferation of non-small cell lung cancer cells by activating the Wnt signaling pathway via the miR-155/AXIN1 axis.
Shi XY; Tao XF; Wang GW; He JF; Wu LF; Sun YZ; Sun XJ
Eur Rev Med Pharmacol Sci; 2021 Jan; 25(1):139-144. PubMed ID: 33506901
[TBL] [Abstract][Full Text] [Related]
10. Highly expressed long non-coding RNA FOXD2-AS1 promotes non-small cell lung cancer progression via Wnt/β-catenin signaling.
Rong L; Zhao R; Lu J
Biochem Biophys Res Commun; 2017 Mar; 484(3):586-591. PubMed ID: 28132805
[TBL] [Abstract][Full Text] [Related]
11. lncRNA HOXC-AS1 promotes gastric cancer via binding eIF4AIII by activating Wnt/β-catenin signaling.
Zhou C; An N; Cao C; Wang G
J Gene Med; 2020 Sep; 22(9):e3202. PubMed ID: 32307743
[TBL] [Abstract][Full Text] [Related]
12. LncRNA TMPO-AS1 facilitates the proliferation and metastasis of NSCLC cells by up-regulating ERBB2 via sponging miR-204-3p.
Yu X; Lin Q; Liu F; Yang F; Mao J; Chen X
Int J Immunopathol Pharmacol; 2020; 34():2058738420958947. PubMed ID: 32969763
[TBL] [Abstract][Full Text] [Related]
13. LncRNA DSCAM-AS1 promotes non-small cell lung cancer progression via regulating miR-577/HMGB1 axis.
Qiu Z; Pan XX; You DY
Neoplasma; 2020 Jul; 67(4):871-879. PubMed ID: 32386483
[TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA DLEU7-AS1 promotes the occurrence and development of colorectal cancer via Wnt/β-catenin pathway.
Liu XB; Han C; Sun CZ
Eur Rev Med Pharmacol Sci; 2018 Jan; 22(1):110-117. PubMed ID: 29364477
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of LncRNA FAM83H-AS1 in hepatocellular carcinoma promotes cell proliferation, migration and invasion by Wnt/β-catenin pathway.
Ma YK; Shen TH; Yang XY
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):7855-7862. PubMed ID: 31599410
[TBL] [Abstract][Full Text] [Related]
16. LncRNA SNHG12 promotes the proliferation and metastasis of papillary thyroid carcinoma cells through regulating wnt/β-catenin signaling pathway.
Ding S; Qu W; Jiao Y; Zhang J; Zhang C; Dang S
Cancer Biomark; 2018; 22(2):217-226. PubMed ID: 29630517
[TBL] [Abstract][Full Text] [Related]
17. Study on expression of lncRNA RGMB-AS1 and repulsive guidance molecule b in non-small cell lung cancer.
Li P; Li J; Yang R; Zhang F; Wang H; Chu H; Lu Y; Dun S; Wang Y; Zang W; Du Y; Chen X; Zhao G; Zhang G
Diagn Pathol; 2015 Jun; 10():63. PubMed ID: 26055877
[TBL] [Abstract][Full Text] [Related]
18. SP1-regulated LINC01638 promotes proliferation and inhibits apoptosis in non-small cell lung cancer.
Guo L; Fang L; Liu Y
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8913-8920. PubMed ID: 31696478
[TBL] [Abstract][Full Text] [Related]
19. A Peptide Encoded by a Long Non-Coding RNA DLX6-AS1 Facilitates Cell Proliferation, Migration, and Invasion by Activating the wnt/β-Catenin Signaling Pathway in Non-Small-Cell Lung Cancer Cell.
Xu X; Zhang Y; Wang M; Zhang X; Jiang W; Wu S; Ti X
Crit Rev Eukaryot Gene Expr; 2022; 32(8):43-53. PubMed ID: 36017915
[TBL] [Abstract][Full Text] [Related]
20. Long noncoding RNASEH1-AS1 exacerbates the progression of non-small cell lung cancer by acting as a ceRNA to regulate microRNA-516a-5p/FOXK1 and thereby activating the Wnt/β-catenin signaling pathway.
Zhang C; Huang J; Lou K; Ouyang H
Cancer Med; 2022 Apr; 11(7):1589-1604. PubMed ID: 35166053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
